147
Views
6
CrossRef citations to date
0
Altmetric
Endoscopy

Does heparin coating reduce encrustation of biliary plastic endoprostheses? A prospective randomized trial

, , &
Pages 1141-1147 | Received 21 Mar 2012, Accepted 09 Jul 2012, Published online: 06 Aug 2012

References

  • Soehendra N, Reynders-Fredrix V. Palliative bile duct drainage – a new endoscopic method of introducing a transpapillary drain. Endoscopy 1980;12:8–11.
  • Dowidar N, Moesgaard F, Matzen P. Clogging and other complications of endoscopic biliary endoprostheses. Scand J Gastroenterol 1991;26:1132–6.
  • Huigbregtse K, Tytgat GN. Palliative treatment of obstructive jaundice by transpapillary introduction of large bore bile duct endoprosthesis. Gut 1982;23:371–5.
  • Farnbacher MJ, Voll RE, Faissner R, Wehler M, Hahn EG, Löhr M, Composition of clogging material in pancreatic endoprostheses. Gastrointest Endosc 2005;61:862–6.
  • Ikenberry SO, Sherman S, Hawes RH, Smith M, Lehman GA. The occlusion rate of pancreatic stents. Gastrointest Endosc 1994;40:611–13.
  • Choong S, Wood S, Fry C, Whitfield H. Catheter associated urinary tract infection and encrustation. Int J Antimikrob Agents 2001;17:305–10.
  • Gianfranco D, Guaglianone E, Di Rosa R, Fiocca F, Basoli A. Plastic biliary stent occlusion: factors involved and possible preventive approaches. Clin Med Res 2007;5:53–60.
  • Leung JW, Ling TK, Kung JL, Vallance-Owen J. The role of bacteria in the blockage of biliary stents. Gastrointestin Endosc 1988;34:19–22.
  • Speer AG, Cotton PB, Rode J, Seddon AM, Neal CR, Holton J, Biliary stent blockage with bacterial biofilm. A light and electron microscopy study. Ann Intern Med 1988;108:546–53.
  • Leung JW, Liu Y, Chan RC, Tang Y, Mina Y, Cheng AF, Early attachment of anaerobic bacteria may play an important role in biliary stent blockage. Gastrointest Endosc 2000;52:725–9.
  • Maxton DG, Tweedle DE, Martin DF. Retained common bilde duct stones after endoscopic sphincterotomy: Temporary and longterm treatment with biliary stenting. Gut 1995;36:446–9.
  • Luman W, Ghosh S, Palmer KR. A combination of ciprofloxacin and Rowachol does not prevent biliary stent occlusion. Gastroinest Endosc 1999;49:316–21.
  • Chan G, Barkun AN, Valois E, Cohen A, Friedmann G, Parent J, The role of ciprofloxacin in prolonging polyethylene biliay stent patency: a multicenter, double-blinded effectiveness study. J Gastrointest Surg 2005;9:481–8.
  • Tsang TK, Pollack J, Chodash HB. Inhibition of biliary endoprostheses occlusion by ampicillin-sulbactam in an in vitro model. J Lab Clin Med 1997;130:643–8.
  • Sung JJ, Solano J, Lai CW, Ismael A, Yung MY, Tumala I, Long-term ciprofloxacin treatment for the prevention of biliary stent blockage: a prospective randomized study. Am J Gastroenterol 1999;94:3197–201.
  • Leung JW, Lau GT, Sung JJ, Costerton JW. Decreased bacterial adherence to silver-coated stent material: an in vitro study. Gastrointest Endosc 1992;38:338–40.
  • Galandi D, Schwarzer G, Bassler D, Allgaier HP. Ursodesoxycholic acid and/or antibiotics for prevention of biliary stent occlusion. Chochrane Database Syst Rev 2002;3:CD003043.
  • Coene PP, Groen AK, Davids PH, Hardeman M, Tytgat GN, Huigbregtse K. Bile viscosity in patients with biliary drainage. Effect of co-trimoxazole and N-acetylcysteine and role in stent clogging. Scand J Gastroenterol 1994;29:757–63.
  • Jansen B, Goodman LP, Ruiten D. Bacterial adherence to hydrophilic polymer-coated polyurethane stents. Gastrointest Endosc 1993;39:670–3.
  • Seitz U, Block A, Schaefer AC, Wienhold U, Bohnacker S, Siebert K, Biliary stent clogging solved by nanotechnology? In vitro study of inorganic-organic sol-gel coatings for teflon stents. Gastroenterology 2007;133:65–71.
  • England RE, Martin DF, Morris J, Sheridan MB, Frost R, Freeman A, A prospective randomised multicenter trial comparing 10 Fr Teflon Tannenbaum stents with 10 Fr polyethylene Cotton-Leung stents in patients with malignant common duct strictures. Gut 2000;46:395–400.
  • Terruzzi V, Comin U, De Granzia F, Toti GL, Zambelli A, Beretta S, Prospective randomized trial comparing Tannenbaum Teflon and standard polyethylene stents in distal malignant biliary stenosis. Gastrointest Endosc 2000;51:23–7.
  • Nakamura S, Ohara H, Yamada T, Nakazawa T, Sano H, Ando H, Efficacy of plastic tube stents without side holes for middle and lower biliary strictures. J Clin Gastroenterol 2002;34:77–80.
  • Reddy DN, Banerjee R, Choung OW. Antireflux biliary stents: are they the solution to stent occlusions? Curr Gastroenterol Rep 2006;8:156–60.
  • Rees EN, Tebbs SE, Elliott TS. Role of antimicrobial-impregnated polymer and Teflon in the prevention of biliary stent blockage. J Hosp Infect 1998;39:323–9.
  • Hildebrandt P, Glycosaminoglycans - all round talents in coating technology. Biomed Tech 2002;47:476–8.
  • Ruggieri MR, Hanno PM, Levin RM. Reduction of bacterial adherence to catheter surface with heparin. J Urol 1987;138:423–6.
  • Hildebrandt P, Sayyad M, Rzany A, Schaldach M, Seiter H. Prevention of surface encrustation of urological implants by coating with inhibitors. Biomat 2001;22:503–7.
  • Riedl CR, Witkowski M, Plas E, Pflueger H. Heparin coating reduces encrustation of ureteral stents: a preliminary report. Int J Antimicrob Agents 2002;19:507–10.
  • Cauda F, Cauda V, Fiori C, Onida B, Garrone E. Heparin coating on ureteral double J stents prevents encrustations: an in vivo case study. J Endourol 2008;22:465–72.
  • Lange D, Elwood CN, Choi K, Hendlin K, Monga M, Chew BH. Uropathogen interaction with the surface of urological stents using different surface properties. J Urol 2009;182:1194–200.
  • Denstedt JD, Cadieux PA. Eliminating biofilm from ureteral stents: the Holy Grail. Curr Opin Urol 2009;19:205–10.
  • Tenke P, Riedl CR, Jones GL, Williams GJ, Stickler D, Nagy E. Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy. Int J Antimicrob Agents 2004;23:S67–74.
  • Chopra KB, Peters RA, O´Toole PA, Williams SG, Gimson AE, Lombard MG, Randomized study of endoscopic biliary endosprosthesis versus duct clearance for bile duct stones in high risk patients. Lancet 1996;348:791–3.
  • Speer AG, Cotton PB, Russel RC, Mason RR, Hatfield AR, Leung JW, Randomized trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987;2:57–62.
  • Bilbao MK, Dotter CT, Lee TG, Katon RM. Complications of endoscopic retrograde cholangiopancreaticography (ERCP). A study of 10.000 cases. Gastroenterol 1976;70:314–20.
  • Groen AK, Out T, Huibregtse K, Delzenne B, Hoek FJ, Tytgat GN. Characterization of the content of occluded biliary endoprostheses. Endoscopy 1987;19:57–9.
  • McAllister EW, Carey LC, Brady PG, Heller R, Kovacs SG. The role of polymeric surface smoothness of biliary stents in bacterial biofilm deposition and stent occlusion. Gastrointest Endosc 1993;39:422–5.
  • Fellstroem B, Danielson BD, Karlsson FA, Ljunghall S. Crystal inhibition: binding of heparin and chondroitin sulphate to calcium oxalate, sodium urate and uric acid crystals. Urolithiasis and rel clin res. New York: Plenum Press; 1985. pp 831–4.
  • Lammert F, Neubrand MW, Bittner R, Feussner H, Greiner L, Hagenmüller F, S3-Guidelines for diagnosis and treatment of gallstones. Z Gastroenterol 2007;45:971–1001.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.